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Abstract Many software solutions are available for proteomics and glycomics studies, but none 
are ideal for the structural analysis of peptidoglycan (PG), the essential and major component of 
bacterial cell envelopes. It icomprises glycan chains and peptide stems, both containing unusual 
amino acids and sugars. This has forced the field to rely on manual analysis approaches, which are 
time- consuming, labour- intensive, and prone to error. The lack of automated tools has hampered the 
ability to perform high- throughput analyses and prevented the adoption of a standard methodology. 
Here, we describe a novel tool called PGFinder for the analysis of PG structure and demonstrate 
that it represents a powerful tool to quantify PG fragments and discover novel structural features. 
Our analysis workflow, which relies on open- access tools, is a breakthrough towards a consistent and 
reproducible analysis of bacterial PGs. It represents a significant advance towards peptidoglycomics 
as a full- fledged discipline.
Introduction
The characterisation of bacterial cell walls started with the development of electron microscopy tech-
niques (Mudd and Lackman, 1941), and it has ever since been the focus of countless studies. The 
major and essential component of the bacterial cell envelope is called peptidoglycan (PG). It confers 
cell shape and resistance to osmotic stress and represents an unmatched target for antibiotics (Main-
ardi et al., 2008; Vollmer et al., 2008). Some of the most widely used antibiotics to date (beta- 
lactams and glycopeptides) inhibit the polymerisation of PG.
PG (murein; originally known as mucopeptide) is a giant, insoluble, bag- shaped molecule, and 
its composition was characterised soon after its discovery (Cummins and Harris, 1956; Rogers 
and Perkins, 1959; Weidel and Pelzer, 1964). It is composed of glycan chains containing alter-
nating N- acetylglucosamine (GlcNAc) and N- acetylmuramic acid (MurNAc) residues linked by β,1–4 
bonds. The lactyl group of MurNAc residues is substituted by pentapeptide stems which often has 
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the L- Ala1-γ-D- Glu2- L- DAA3- D- Ala4- D- Ala5 sequence, where DAA is a diamino acid such as meso- 
diaminopimelic (mDAP) acid or L- lysine (Figure 1a; Vollmer et al., 2008). In some species, a lateral 
chain (with variable composition and length) can be found attached to the amino acid in position 
3. Peptide stem composition and polymerisation can vary amongst bacterial species (Schleifer and 
Kandler, 1972). Whilst PG building blocks produced in the cytoplasm are always the same, the final 
structure undergoes constant lysis and modification, a process referred to as ‘remodelling’. Both 
remodelling and alternative polymerisation modes (Figure 1b) lead to a considerable variation in PG 
structure during cell growth and division. PG structural plasticity plays a critical role for adaption to 
environmental conditions during host- pathogen interaction (Boneca et al., 2007; Juan et al., 2018) 
or to survive exposure to antibiotics (Mainardi et al., 2008).
PG material is straightforward to purify, but the structural analysis of this molecule is challenging 
and remains a time- consuming and labour- intensive process. The intact molecule must be broken 
down into soluble fragments by enzymatic digestion with a glycosyl hydrolase (lysozyme), and 
individual building blocks (disaccharide peptides, also called muropeptides) are analysed to gain 
insight into the structure of the intact molecule. A transformative step for the characterisation of 
disaccharide peptides has been the use of reversed- phase HPLC (rp- HPLC) and mass spectrometry 
(MS) towards the end of the 1990s  (Garcia- Bustos et al., 1988; Glauner, 1988; Glauner et al., 
1988; Martin et al., 1987). Combining muropeptides separation by rp- HPLC and MS characterisa-
tion has hinted at a more complex structure than previously reported.
Despite tremendous advances in both rp- HPLC- MS instrumentation and software development 
for the automated analysis of large datasets, ‘peptidoglycomics’ is still in its infancy. The experi-
mental strategy to analyse PG structure has barely changed over the past 30 years. Even though 
rp- HPLC- MS has been routinely used over the past decade, the analysis of MS data remains a black 
box. Except for a recent study describing the PG structure of Pseudomonas aeruginosa (Anderson 
et al., 2020b), no information is available in the literature about the strategy used to identify muro-
peptides in rp- HPLC- MS datasets. This task relies on searching a subset of expected structures, but 
the complexity of both the search space and search process is often not described.
We previously provided the proof of concept that shotgun proteomics tools can be used for the 
automated and unbiased analysis of PG structure (Bern et al., 2017). The analysis of Clostridioides 
(previously Clostridium) difficile PG led to the identification of many muropeptides never reported 
before. This work also demonstrated that PG analysis could be carried out with relatively high 
throughput, opening the possibility to analyse large numbers of samples (such as clinical or envi-
ronmental isolates) using a minimal amount of material (typically microgram amounts).
Here, we describe a novel software called PGFinder for the analysis of MS data. PGFinder is 
a versatile and straightforward open- source software tool that allows automated identification of 
muropeptides based on the creation of dynamic databases. Sharing PGFinder as a Jupyter Note-
book provides a robust and consistent pipeline with the potential to accelerate discovery in the 
field of peptidoglycomics. This workflow described here allows a comprehensive description of the 
analysis strategy for a consistent and reproducible PG structure analysis by users in the community.
We applied the PGFinder pipeline to analyse the muropeptides composition of Escherichia coli 
which has been extensively studied. We demonstrate that PGFinder can capture an unprecedented 
level of complexity of PG structure, highlighting the limitations of the search strategies reported 
so far. Finally, we provide evidence that PGFinder can be used in conjunction with freely available 
MS data deconvolution software, making PG analysis possible using entirely open- access tools. We 
propose that our approach represents a significant advance towards a consistent and reproducible 
analysis of PG structure, allowing peptidoglycomics to take the crucial first leap to parity with other 
omics disciplines.
Results
PGFinder: a dedicated script for bottom-up identification of PG 
fragments
No pipeline is currently available for the automated analysis of MS PG data. Therefore, we sought 
to replicate a shotgun proteomics approach to create an analysis pipeline dedicated to PG analysis, 
referred to as ‘peptidoglycomics’ (Wheeler et al., 2014).
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Figure 1. Diversity of peptidoglycan composition and structure. (a) Representative peptidoglycan building block made of N- acetylglucosamine 
(GlcNAc) and N- acetylmuramic acid (MurNAc) forming a disaccharide subunit linked to a pentapeptide stem attached to the MurNAc via a lactyl moiety. 
Peptide stem contains both L and D- amino acids and show a great diversity in composition. Some examples of amino acids found in peptidoglycan 
are shown for each residue. Modifications of the sugars are also shown. (b) Representation of crosslinking diversity, 4–3 bonds (direct or via peptide 
Figure 1 continued on next page
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To limit misidentifications due to mass coincidences, we established a search strategy relying on an 
iterative process (Figure 2). A first search was carried out using a database made of reduced disac-
charide peptides (monomers) and their theoretical monoisotopic masses. MS data were deconvoluted 
using the Protein Metrics Byos software to generate a list of observed monoisotopic masses along-
side other parameters including retention times and signal intensity. Individual theoretical masses 
contained in the monomer database (Figure 2, database 1) were compared with observed masses 
in the experimental dataset. Any observed mass within 10 ppm tolerance was considered as a match 
and the corresponding inferred structure and theoretical mass were then added to a list of matched 
structures (Figure 2, library 1). As a second step, we used the list of matched monomers to build 
another database in silico (Figure  2, database 2), corresponding to dimers and trimers and their 
theoretical masses. Two types of polymerisation events are included in the original PGFinder version 
depending on the type of crosslink either through peptide stems or glycan chains. Individual theo-
retical masses from the in silico database were compared to observed masses to generate a list of 
matched dimers and trimers (Figure 2, library 2). As a third step, we combined the lists of matched 
monomers and multimers to generate a final library of modified muropeptides (Figure 2, library 3). 
The final library contained only modified muropeptides corresponding to matched monomers, dimers, 
and trimers. The modifications accounted for include the presence of anhydro groups, deacetylated 
sugars, amidated amino acids, and modifications resulting from N- acetylglucosaminidase or amidase 
activities (loss of GlcNAc and lack of peptide stems, respectively). In- source decay products (loss 
of GlcNAc) and Na+/K+ salt adducts were also added to library 3. All three libraries corresponding 
to observed monomers, dimers, trimers, and their modified variants were combined to search the 
MS data for masses matching theoretical values within a 10 ppm mass accuracy window. This search 
generated results processed by PGFinder to carry out a ‘clean up step’. The intensities of in- source 
decay products and salt adducts were combined with that from parent ions when found within close 
crossbridge) and 3–3 bonds are made by D,D- or L,D- transpeptidases, respectively. The enzymes catalysing 1–3 and 4–2 bonds remain unknown. 
Acceptors stems are shown in blue and donor stems in red. DAA: diamino acid; m- DAP: meso- diaminopimelic acid; D- Lac: D- lactate; X: cell surface 
polymer (e.g teichoic acid); Z: lateral chain.
Figure 1 continued
Figure 2. Flowchart outlining the algorithm for the matching script. The identification of muropeptides was carried out using four successive steps, 
indicated by different colours (orange, green, blue, and red, respectively). As a first step, observed masses in the dataset are compared to a list of 
theoretical masses corresponding to monomers (database 1). Matched masses within the ppm tolerance set (10 ppm for Orbitrap data) are used to 
build a list of inferred monomeric structures and their corresponding theoretical masses (library 1). This is then used to generate a list of theoretical 
multimers (dimers and trimers) and their masses (database 2). A second matching round is carried out to build a list of inferred multimers (library 2). At 
this stage, matched monomers and multimers are combined to generate a list of modified muropeptides (library 3). Two libraries of matched theoretical 
masses (monomers and dimers, trimers) and a third library (their modified counterparts) are used to search the dataset. Muropeptide structures are 
inferred from a match within tolerance between theoretical and observed masses. This data is then ‘cleaned up’ by combining the intensities of ions 
corresponding to in- source decay and salt adducts to those of parent ions. The final matched mass spectrometry data is then written to a .csv file.
 Tools and resources Microbiology and Infectious Disease
Patel et al. eLife 2021;0:e70597. DOI: https:// doi. org/ 10. 7554/ eLife. 70597  5 of 22
retention time (a 0.5 min time window). The output of this final step is a matched table written to a .csv 
format file. It contained all the inferred structures identified within the specified mass and retention 
time windows with an extracted- ion chromatogram (XIC) signal intensity for quantification.
Using PGFinder to investigate PG structure and identify low-abundance 
muropeptides
The performance of the matching script was tested using the well- characterised PG from E. coli as 
a proof of concept. UHPLC- MS/MS data were acquired for three independent PG samples (biolog-
ical replicates; Appendix 1—figure 1). Following MS1 spectral deconvolution (a process calculating 
masses from observed m/z values), observed masses were matched to theoretical muropeptides 
masses according to the strategy described above (Figure 2). A first search was carried out using 
a minimal mass database made of 10 simple PG fragments including three glycan chains (di-, tetra-, 
and hexasaccharides) and seven monomers (Table 1—source data 1). Due to the .csv format of the 
database, the diamino acid in position 3 could not be assigned to a symbol or Greek letter and had 
to be one of the 26 letters already assigned by the IUPAC- IUB Joint Commission on Biochemical 
Nomenclature. We used the letter J for mDAP for the initial search and replaced it by the letter m in 
the final table. The output of the automated search is a .csv file per dataset; all files corresponding to 
biological replicates were collated into one Excel file (Table 1—source data 2). Each search output 
contained approximately 3000 rows of masses and corresponding parameters. Depending on the 
dataset analysed, 41–48% of the total ion intensity was assigned to PG structures. As anticipated, 
inferred structures were frequently found with multiple retention times, reflecting the existence of 
stereoisomers, with one species accounting for most of the intensity. In some cases, observed masses 
matched with more than one inferred structure. The output of the automated search was consoli-
dated as described in Supplementary file 1. Retention times were assigned to individual structures 
based on the elution of the most abundant stereoisomer. For example, >97% of the most abundant 
monomer GM- AEJA was eluted at an average retention time of 10.04 ± 0.04 min. Data consolida-
tion revealed an unprecedented muropeptide composition complexity compared to recent LC- MS 
analyses of E. coli (Kühner et al., 2014; Table 1—source data 2). Sixty PG fragments were identified 
(Table 1): these included glycan chains lacking peptide stems (4.38%), monomers (63.14%), dimers 
(29.54%), and trimers (2.94%) (Figure 3). Based on the abundance of multimeric PG fragments, we 
report a crosslinking index of 15.69%, which is slightly lower than the value previously reported of 
23.1%  (Glauner, 1988).
The automated and unbiased search revealed several muropeptides that were expected but never 
reported to date for E. coli. These included (i) PG fragments resulting from amidase activity (4.55%), 
found as ‘denuded glycans’ (disaccharides and tetrasaccharides) and modified variants or muropep-
tide stem with an extra disaccharide residue; (ii) a low- abundance (0.23%) PG fragments containing 
deacetylated GlcNAc residues; and (iii) PG fragments resulting from glucosaminidase activity (0.12%). 
Deacetylated muropeptides were not expected since no E. coli PG deacetylase has been identi-
fied in this organism to date. All the structures identified for the first time (glycan chains, monomers 
containing deacetyl groups, and muropeptides lacking a GlcNAc residue) were confirmed by MS/
MS analysis (Table 1—source data 3). The proportion of muropeptides with anhydroMurNAc groups 
identified (4.55%) was in line with previous studies, yielding an average chain length of 36.05. This 
value is higher than an earlier study that reported a predominant chain length of 5–10 disaccha-
ride units (Harz et al., 1990), but agreed with recent work that reported long glycan chains in E. 
coli (Turner et  al., 2018). Overall, the quantification of muropeptides across biological replicates 
was very consistent, with Pearson’s correlation coefficients >0.96 (Appendix 1—figure 2). The most 
pronounced variations in quantification were observed with low- abundance muropeptides accounting 
for less than 1%  of the species identified.
We further explored the structural diversity of E. coli PG, performing a more complex search with a 
mass database made of glycan chains and all possible monomers containing di-, tri-, tetra-, and penta-
peptide stems (Table 1—source data 4; 224 structures in total). Several monomers with tetra- and 
pentapeptide stems containing unusual amino acids were identified. Only four structures could be 
confirmed by MS/MS analysis and corresponding multimers were retained (GM- AEJF, -AEJN, AEJK, 
-AEJAK, and GM- AEJKD). Collectively, muropeptides containing unusual amino acids accounted for 
ca. 7.5%  of the 80 structures identified (Table 1—source data 5) using a complex mass database.
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(%) Monoisotopic mass (Da)
Av±SD Av±SD Obs Theo Δppm
GM|0 3.62±0.01 3.465±0.683 498.205 498.206 2.5
Glycans GM (x2)|0 10.11±0.03 0.428±0.349 976.384 976.386 2.2
4.38%±0.35% GM (anhydro) |0 8.20±1.92 0.238±0.025 478.179 478.180 2.9
GM (deacetyl) |0 2.57±0.00 0.155±0.032 456.194 456.196 3.5
GM (x2) (deacetyl) |0 6.86±0.02 0.093±0.012 934.372 934.376 3.2
GM- AEmA|1 10.04±0.04 36.098±2.131 941.405 941.408 2.8
GM- AEm|1 6.57±0.01 14.352±0.397 870.368 870.371 3.0
GM- AEmKR|1 9.56±0.05 8.030±0.774 1154.563 1154.567 3.6
GM- AE|1 9.57±0.04 1.809±0.231 698.284 698.286 3.1
GM- AEmG|1 7.85±0.05 0.689±0.049 927.390 927.392 2.3
GM- AEm (anhydro) |1 13.98±0.02 0.668±0.073 850.342 850.344 2.2
Monomers GM- AEmA (anhydro) |1 16.55±0.01 0.573±0.100 921.380 921.382 2.0
63.14%±1.13% GM- AEmAG|1 9.45±0.05 0.219±0.009 998.426 998.429 3.1
GM- AEmKR (anhydro) |1 14.83±0.01 0.160±0.039 1134.537 1134.540 2.9
GM- AEmA (deacetyl) |1 8.57±0.06 0.083±0.055 899.394 899.397 3.1
GM- GM- AEmA|1 13.10±0.02 0.075±0.040 1419.584 1419.588 2.9
GM- AE (anhydro) |1 17.44±0.01 0.069±0.013 678.258 678.260 2.8
M- AEm|1 4.56±0.01 0.062±0.064 667.289 667.291 3.8
M- AEmKR|1 8.16±0.06 0.061±0.056* 951.484 951.487 3.2
GM- AEmAA|1 11.38±0.04 0.059±0.003 1012.442 1012.445 2.4
M- AEmA|1 8.52±0.05 0.053±0.015 738.325 738.328 4.0
GM- GM- AEm|1 11.31±0.04 0.042±0.025 1348.547 1348.551 2.4
GM- AEm (deacetyl) |1 4.77±0.01 0.024±0.014 828.358 828.360 3.0
GM- GM- AEmKR|1 12.18±0.03 0.011±0.002* 1632.742 1632.747 3.0
GM- AEmA- GM- AEmA|2 16.01±0.02 17.247±0.777 1864.800 1864.805 2.3
GM- AEmA- GM- AEmKR|2 14.83±0.02 4.589±0.589 2077.957 2077.964 3.0
GM- AEmA- GM- AEm|2 15.09±0.02 3.207±0.168 1793.763 1793.768 2.6
GM- AEmA- GM- AEmA (anhydro) |2 20.56±0.01 0.873±0.037 1844.774 1844.778 2.4
GM- AEm- GM- AEmKR|2 14.22±0.00 0.855±0.101 2006.920 2006.926 3.3
GM- AEmA- GM- AEmKR (anhydro) |2 18.89±0.17 0.665±0.079 2057.934 2057.937 1.8
GM- AEm- GM- AEm|2 14.23±0.01 0.558±0.062 1722.725 1722.730 3.0
GM- AEm- GM- AEmAG|2 14.68±0.01 0.416±0.025 1850.785 1850.789 2.4
GM- AEmA- GM- AEm (anhydro) |2 19.66±0.01 0.381±0.028 1773.738 1773.741 2.1
Dimers GM- AEmA- GM- AEmAG|2 15.33±0.02 0.179±0.005 1921.822 1921.826 2.2
29.54%±0.46% GM- AEm- GM- AEmKR (anhydro) |2 18.07±0.01 0.170±0.024 1986.896 1986.900 2.1
GM- AEm- GM- AEm (anhydro) |2 18.77±0.01 0.141±0.015 1702.697 1702.704 4.5
GM- AEmA- GM- AEmAA|2 16.54±0.01 0.075±0.002 1935.838 1935.842 2.1
Table 1 continued on next page
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(%) Monoisotopic mass (Da)
Av±SD Av±SD Obs Theo Δppm
GM- AEm- GM- AEmG|2 13.91±0.01 0.054±0.003 1779.747 1779.752 2.7
GM- GM- AEmA- GM- AEmA|2 17.51±0.01 0.046±0.028 2342.976 2342.985 3.6
GM- AEmA- GM- AEmA (deacetyl) |2 15.17±0.01 0.029±0.022 1822.789 1822.794 3.0
GM- AEmA- GM- AEmG (anhydro) |2 19.12±0.01 0.021±0.001 1830.761 1830.763 0.7
GM- AEmA- GM- AEmAG (anhydro) 
|2 19.73±0.01 0.019±0.002 1901.796 1901.800 2.1
GM- AEmA- GM- AEmAA (anhydro) 
|2 21.17±0.02 0.015±0.002 1915.812 1915.816 1.8
GM- GM- AEmA- GM- AEm|2 16.85±0.00 0.003±0.004 2271.943 2271.947 2.1
GM- AEmA- GM- AEmA- GM- AEmA|3 18.86±0.01 1.751±0.221 2788.192 2788.202 3.5
GM- AEmA- GM- AEmA- GM- AEm|3 18.23±0.21 0.371±0.031 2717.158 2717.164 2.2
GM- AEmA- GM- AEmA- GM- AEmA 
(anhydro) |3 22.39±0.02 0.222±0.027 2768.169 2768.175 2.3
GM- AEmA- GM- AEmA- GM- 
AEmKR|3 17.54±0.01 0.207±0.028 3001.350 3001.360 3.4
GM- AEmA- GM- AEmA- GM- AEm 
(anhydro) |3 21.60±0.02 0.117±0.003 2697.133 2697.138 1.8
Trimers
GM- AEmA- GM- AEmA- GM- AEmKR 
(anhydro) |3 20.90±0.16 0.088±0.026 2981.328 2981.334 2.2
2.94%±0.36%
GM- AEmA- GM- AEmA- GM- 
AEmG|3 17.72±0.01 0.039±0.004 2774.182 2774.186 1.4
GM- AEmA- GM- AEm- GM- AEm|3 17.45±0.01 0.029±0.005 2646.123 2646.127 1.7
GM- AEmA- GM- AEm- GM- AEm 
(anhydro) |3 21.16±0.01 0.025±0.001 2626.096 2626.101 1.9
GM- AEmA- GM- AEm- GM- AEmKR|3 17.11±0.01 0.022±0.002 2930.316 2930.323 2.7
GM- AEmA- GM- AEmA- GM- 
AEmAG|3 18.24±0.01 0.021±0.001 2845.217 2845.223 2.0
GM- AEmA- GM- AEmA- GM- 
AEmAA|3 19.23±0.01 0.014±0.002* 2859.235 2859.239 1.3
GM- AEmA- GM- AEm- GM- AEmKR 
(anhydro) |3 20.31±0.02 0.014±0.005 2910.293 2910.297 1.5
GM- AEm- GM- AEmG- GM- 
AEmAG|3 17.18±0.00 0.004±0.005 2703.143 2703.149 2.0
GM- AEmA- GM- AEm- GM- AEmG 
(anhydro) |3 21.21±0.02 0.011±0.003* 2754.157 2754.160 1.1
GM- AEmA- GM- AEmA- GM- AEmAG 
(anhydro) |3
21.77±0.01 0.006±0.004 2825.189 2825.197 2.8
Inferrred dimers and trimers are based on the most abundant monomers and could correspond to alternative 
structures.
G: GlcNAc; M: MurNAc; m: meso- diaminopimelic acid; the number following the symbol ‘|’ refers to the 
oligomerisation state (1 for monomers, 2 for dimers, and 3 for trimers).
*Calculated from two values.
The online version of this article includes the following source data for table 1:
Source data 1. E. coli simple mass database.
Source data 2. E. coli matching output and consolidated data.
Source data 3. MS/MS analysis of E. coli glycan chains and monomers.
Table 1 continued
Table 1 continued on next page
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Using PGFinder for the comparative analysis of PG structures
We showed with E. coli data that PGFinder is suitable to characterise the high- resolution structure 
of PGs using a ‘bottom- up’ approach. However, this requires a careful analysis of the search output 
to confirm the identity of muropeptides identified and discriminate between multiple structures that 
can be assigned to a unique observed mass. A more basic application is the use of PGFinder in 
organisms that have already been studied in detail to either compare PG composition or quantify 
the abundance of specific structures. This application accounts for most PG analyses described in the 
Source data 4. E. coli complex mass database.
Source data 5. E. coli muropeptide complex table.
Table 1 continued
Figure 3. Distribution of E. coli peptidoglycan fragments identified using automated search workflow. Breakdown of peptidoglycan is shown by 
oligomerisation state (left) branching to specific composition (right). Branch size is proportional to percentage. Monomers, dimers, trimers, and 
glycan chains (left) are broken down into muropeptide composition and structure (right). Individual structures are grouped by colour according to 
oligomerisation state. Monomers, green; dimers, yellow; trimers, orange. Residues in square brackets are only found in some muropeptides. For 
example, GM- AEJ[A]-GM- AEJ[A] can represent GM- AEJA- GM- AEJA, GM- AEJA- GM- AEJ, and GM- AEJ- GM- AEJ. G: N- acetylglucosamine; M, N- 
acetylmuramic acid; A: L- or D- alanine; E: γ-D- glutamic acid; J: meso- diaminopimelic acid; K: D- lysine; R: D- arginine; G: glycine.
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literature, comparing PG structures between different isolates, isogenic mutants, or cells grown in 
different conditions.
We chose the PG of C. difficile as a proof of concept to demonstrate how PGFinder can carry out 
a straightforward comparative analysis. We prepared PG samples corresponding to biological tripli-
cates from two clinical isolates, R20291 and M7404. To illustrate the versatility of the software, PG 
samples were digested by mutanolysin, and disaccharide peptides were beta- eliminated to generate 
lactyl- peptides (Tipper, 2002) and analysed by UHPLC- MS (Figure 4—figure supplement 1). Since 
the high- resolution PG structure of C. difficile has been described based on the MS/MS analysis of 
muropeptides (Bern et al., 2017), we used data previously published to build a PG fragment data-
base for a ‘one- off’ matching step. The database included monomers identified by MS/MS, containing 
unusual amino acids and the corresponding dimers resulting from either D,D- or L,D- transpeptidation 
(with a AEJA or AEJ peptide as donor stem). To limit the complexity of the search output, we limited 
the list of trimers, tetramers, and pentamers to those containing the most abundant peptide stems 
found in dimers (AEJA, AEJ, or AEJG). The database of theoretical masses contained 74 PG structures 
described in Figure 4—source data 1. MS data were deconvoluted using Byos Feature Finder, and 
observed monoisotopic masses were matched to theoretical masses using PGFinder. To perform the 
matching operation in its simplest form, all options offered by the software were deactivated.
All monomers and dimers searched were identified, except for two muropeptides containing a 
peptide stem with a methionine residue in position four, both present in low abundance in C. difficile 
strain 630 (ca. 0.10%). 25 out of the 31 possible trimers, tetramers, and pentamers searched were 
found (Figure 4—source data 2). Comparison of biological replicates revealed a high reproducibility, 
both in retention times and quantification. A high correlation was found between biological repli-
cates, confirming the robustness of the quantification method (Figure 4a). Both strains contained a 
similar amount of mono-, tri-, tetra-, and pentamers, but strain M7404 contained a significantly lower 
proportion of monomers and a higher proportion of dimers than strain R20291 (p=0.022 and p=0.005, 
respectively; Student’s t- test; Figure 4b). We next performed a Student’s t- test using permutation- 
based FDR to identify statistically significant differences in the abundance of individual muropeptides 
between the two strains. The p- value was plotted on a volcano plot against the fold change in abun-
dance between the two samples (Figure 4c). Two muropeptides were significantly less abundant (Lac- 
AEJ[AG] and Lac- AEJ- Lac- AEJA), and four others were significantly more abundant in strain R20291 
(Lac- AEJV- Lac- AEJA, Lac- AEJ[L/I]-Lac- AEJA, Lac- AEJAA- Lac- AEJA and the trimer (Lac- AEJA)3). 
These differences are likely to reflect different substrate specificities for PBPs and the Ddl ligases in 
these strains. Therefore, combining the output of PGFinder with statistical analysis of muropeptide 
abundance offers a robust workflow to identify differences in PG composition.
Benchmarking the automated PG analysis pipeline using available 
datasets
The analysis of E. coli PG established a proof of concept, showing that our matching script is suitable 
for the automated analysis of PG MS data. We next sought to evaluate the robustness of our pepti-
doglycomics pipeline using available datasets described in the literature. The most suitable publi-
cation was a recent study by Anderson et al. describing a PG analysis of P. aeruginosa planktonic 
cells (Anderson et al., 2020b). Unlike most (if not all) studies published to date, this work provided 
datasets from biological and technical triplicates. Unlike our E. coli samples, analysed on a Q Exactive 
Focus Orbitrap (Thermo), P. aeruginosa samples were analysed on an Agilent Q- TOF mass spec-
trometer. Spectra were deconvoluted using the Byos Feature Finder module, and observed masses 
were matched using a mass tolerance of 25 ppm as described by Anderson et al. To limit the occur-
rence of mass coincidences and misidentification at this slightly lower mass accuracy, we carried out a 
search with PG modifications (anhydroMurNAc residues, deacetylation, lack of peptide stem resulting 
from amidase activity and amidation) but only using the most frequent combinations of modifications 
(double anhydroMurNAc and anhydroMurNAc and deacetyl).
PGFinder identified 63 muropeptides out of the 71 reported by Anderson et al., matching our 
search criteria (Table 2). The eight muropeptides that were not identified were absent from the list 
of deconvoluted masses, indicating that the problem was not associated with the script, highlighting 
that the deconvolution step is a source of variability. Interestingly, the observed masses calculated 
using Byos Feature Finder were closer to the theoretical value (6.5 ppm versus 10.7 ppm on average), 
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R20291.1 R20291.2 R20291.3 M7704.1 M7704.2 M7704.3
R20291.1 NA 0.996 0.995 0.994 0.991 0.994
R20291.2 0.996 NA 0.996 0.995 0.995 0.992
R20291.3 0.995 0.996 NA 0.994 0.993 0.989
M7704.1 0.994 0.995 0.994 NA 0.998 0.995
M7704.2 0.991 0.995 0.993 0.998 NA 0.991











Monomers 52.81% ± 2.09% 46.17% ± 2.38% 0.022
Dimers 36.12% ± 1.48% 43.34% ± 1.74% 0.005
Trimers 10.27% ± 0.64% 9.73% ± 0.67% NS
Tetramers 0.72% ± 0.08% 0.68% ± 0.02% NS
Pentamers 0.07% ± 0.00% 0.06% ± 0.00% NS
Crosslinking index 21.64% ± 0.93% 21.86% ± 0.87% NS
  R20291   M7404
Figure 4. Comparative analysis of C. difficile R20291 and M7404 peptidoglycan (PG) composition. (a) Pearson’s 
correlation coefficients across biological replicates of R20291 and M7404 C. difficile isolates. Heatmap gradient 
shows highest value in green to lowest value in red. (b) Muropeptide distribution according to degree of 
crosslinking. Comparison was carried out using a Student’s t- test; p- value is indicated for each category of 
muropeptides. (c) Volcano plot, where each dot represents an individual muropeptide, plotted against the 
significance (Student’s t- test p- value<0.05, FDR < 0.05, S0 = 0.1) and difference (log2). Muropeptides showing a 
significantly different abundance between strains are highlighted in red. Lac: lactyl group; A: D/L- alanine; E: γ-D- 
glutamate; J: meso- diaminopimelic acid V: D- valine; L: D- leucine; I: D- isoleucine; G: glycine.
The online version of this article includes the following figure supplement(s) for figure 4:
Source data 1. C. difficile mass database.
Figure 4 continued on next page
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reflecting another source of variability associated with data deconvolution. Four muropeptides previ-
ously identified containing the AEJAG pentapeptide stem were matched with distinct structures due 
to a mass coincidence between K and AG. A careful analysis of MS/MS spectra suggested that these 
muropeptides contained a K residue rather than the AG dipeptide (the y2 ion being 143 ppm away 
from the expected mass), showing the added value of an unbiased search. This conclusion is supported 
by the retention times of the corresponding muropeptides since the tetrapeptide AEJK elutes before 
EAJA whilst the pentapeptide AEJAG elutes later in the chromatography (Bern et al., 2017). It is 
worth noting that our search also identified a large number of muropeptides that were not reported 
previously (Table 2—source data 1). These results collectively show that our PG analysis pipeline can 
identify an unprecedentedly large number of muropeptide structures based on MS1 data, including 
all those previously reported (Anderson et al., 2020a; Anderson et al., 2020b).
A PG analysis workflow using freely available tools
The automated identification of P. aeruginosa muropeptides using PGFinder and the strategy reported 
previously (Anderson et al., 2020a; Anderson et al., 2020b) relied on commercially available decon-
volution software (ProteinMetrics Byos or Agilent MassHunter, respectively). We sought to identify 
a free alternative software for mass deconvolution to make our PG analysis pipeline accessible to 
everyone. MaxQuant was selected as a tool of choice since it represents a widely used software 
package to analyse high- resolution mass- spectrometric data for shotgun proteomics (Cox and Mann, 
2008). MaxQuant has native support for Thermo MS data (RAW) and Sciex (WIFF) file formats and 
supports the open MS data format mzXML. Virtually any proprietary MS data file can be converted to 
the mzXML open format using freely available tools such as Proteowizard and TOPPAS, making this 
workflow universally applicable. As proof of concept, we converted P. aeruginosa data to an mzXML 
file (Appendix 2—figure 1), processed it using MaxQuant for mass deconvolution (Appendix 2—
figure 2), and analysed it using PGFinder for PG structure and composition identification. We were 
able to identify all the expected muropeptides (Table 2). This result confirms that the automated 
analysis of PG datasets can be carried out using the MaxQuant freeware and our open- source script 
PGFinder (Table 2 and Table 2—source data 2).
Discussion
This study describes a workflow for the unbiased and automated analysis of bacterial PG using freely 
available resources. We analysed high- resolution MS datasets corresponding to PG fragments and 
demonstrated that this approach is a powerful tool to identify muropeptides and carry out compara-
tive analyses based on the MS1 data.
MS analysis of bacterial PG has been carried out since the late 1980s  (Garcia- Bustos et al., 1988; 
Martin et al., 1987). Whilst rp- HPLC- MS is now routinely used to explore PG structure, data anal-
ysis remains a manual process. Therefore, this step has become a bottleneck that prevents high- 
throughput analyses and introduces a series of issues regarding reproducibility. A major issue deals 
with the definition of the search space used since the list of muropeptides searched is not provided. 
Our previous work showed that an unbiased approach using shotgun proteomics tools identifies 
muropeptides containing unusual amino acids in C. difficile (Bern et al., 2017). Our unbiased search 
identified >106 masses matching E. coli muropeptide structures, representing a number strikingly 
larger than previously reported (Kühner et al., 2014). This level of complexity was anticipated based 
on the complement of enzymes involved in E. coli PG synthesis but had never been reported before. 
Our work therefore highlighted the limitations of search strategies reported so far, especially if we 
consider the fact that some bacterial PGs like E. coli have been extensively studied over the past 
30 years.
Several issues and flaws associated with the manual analysis of PG MS data are addressed by our 
approach, which represents a robust, consistent, and open- access strategy. The PGFinder algorithm 
Source data 2. C. difficile 20291 versus M7404, list of muropeptides, abundance, RT.
Figure supplement 1. C. difficile LC- MS chromatograms.
Figure 4 continued
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GM (anhydro) 478.1799 478.1780 4.0 –2.7 +
GM 498.2061 498.2042 3.9 –4.2 +
GM (x2) (deacetyl) 934.3755 934.3706 5.3 –8.6 +
GM (x2) (anhydro) 956.3598 956.3551 5.0 6.0 +
GM (x2) 976.3860 976.3794 6.7 –6.1 +
GM (x3) (deacetyl) 1412.5554 1412.5490 4.5 –6.2 +
GM (x3) (anhydro) 1434.5397 1434.5348 3.4 –7.5 +
GM (x3) 1454.5659 1454.5592 4.6 –5.3 +
GM (x4) 1932.7458 1932.7352 5.5 –5.1 +
GM- AE (anhydro) 678.2596 678.2567 4.3 –9.1 +
GM- AE 698.2858 698.2830 3.9 –12.9 +
GM- AEJ (anhydro) 850.3444 850.3401 5.1 –10.6 +
GM- AEJ 870.3706 870.3676 3.5 –5.9 +
GM- AEJA (anhydro) 921.3815 921.3765 5.4 –9.9 +
GM- AEJG 927.3920 927.3868 5.6 –8.9 +
GM- AEJA 941.4077 941.4045 3.4 –5.0 +
GM- AEJC 973.3843 973.3763 8.2 –2072.2 +
GM- AEJL 983.4593 983.4498 9.6 –15.5 +
GM- AEJK 998.4703 998.4624 8.0 –10.6 +
GM- AEJM 1001.4153 1001.4060 9.2 –13.5 +
GM- AEJAA 1012.4448 1012.4413 3.4 –7.8 +
GM- AEJY (anhydro) 1013.4091 1013.4242 –14.9 17.8 +
GM- AEJF 1017.4433 1017.4347 8.4 –15.0 +
GM- AEJY 1033.4353 1033.4278 7.2 –5.3 +
GM- AEJAV 1040.4808 1040.4716 8.8 –14.7 +
GM- AEJIA 1054.4964 1054.4874 8.5 –11.3 +
GM- AEJW 1056.4394 1056.4455 –5.8 4.0 +
GM- AEJAM 1072.4524 1072.4460 5.9 –4.3 +
GM- AEJKR 1154.5667 1154.5631 3.1 –8.1 +
GM- GM- AE 1176.4836 1176.4590 20.9 –24.7 +
GM- GM- AEJ 1348.5684 1348.5457 16.9 –24.9 +
GM- GM- AEJA 1419.6055 1419.5824 16.2 –23.5 +
GM- AEJA- GM- AEJ (amidase product) 1313.5721 1313.5674 3.5 –11.0 +
GM- AEJA- GM- AEJA (amidase product) 1384.6092 1384.6037 4.0 –7.4 +
GM- AEJ- GM- AEJ (anhydro) 1702.7042 1702.6976 3.9 38.3 +
GM- AEJ- GM- AEJ 1722.7304 1722.7234 4.1 –8.6 +
GM- AEJA- GM- AEJ (double anhydro) 1753.7151 1753.7043 6.2 –7.2 +
Table 2 continued on next page
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GM- AEJA- GM- AEJ (anhydro) 1773.7413 1773.7339 4.2 –11.1 +
GM- AEJA- GM- AEJ 1793.7675 1793.7596 4.4 –8.8 +
GM- AEJA- GM- AEJA (dacetyl) 1822.7941 1822.7808 7.3 –7.4 +
GM- AEJA- GM- AEJA (double anhydro) 1824.7601 1824.7447 8.4 –15.6 +
GM- AEJA- GM- AEJA (anhydro) 1844.7784 1844.7704 4.3 –8.3 +
GM- AEJA- GM- AEJG 1850.7889 1850.8158 –14.6 9.7 +
GM- AEJA- GM- AEJA 1864.8046 1864.7962 4.5 –6.6 +
GM- AEJA- GM- AEJK (anhydro) 1901.8410 1901.8297 5.9 –14.5 +
GM- AEJA- GM- AEJL 1906.8562 1906.8452 5.8 –11.3 +
GM- AEJA- GM- AEJK 1921.8672 1921.8586 4.5 –12.0 +
GM- AEJA- GM- AEJF 1940.8402 1940.8263 7.2 –8.8 +
GM- AEJA- GM- AEJY 1956.8322 1956.8210 5.7 –7.6 +
GM- AEJA- GM- AEJAL 1977.8933 1977.8813 6.0 –10.7 +
GM- AEJA- GM- AEJKR 2077.9636 2077.9589 2.2 –13.0 +
GM- GM- AEJ- GM- AEJ 2200.9282 2200.9000 12.8 –17.7 +
GM- GM- AEJA- GM- AEJ 2271.9653 2271.9368 12.6 –18.4 +
GM- GM- AEJA- GM- AEJA 2343.0024 2342.9734 12.4 411.4 +
GM- AEJA- GM- AEJA- GM- AEJ (double 
anhydro) 2677.1120 2677.1000 4.5 –10.7 +
GM- AEJA- GM- AEJA- GM- AEJ 
(anhydro) 2697.1382 2697.1259 4.6 –8.6 +
GM- AEJA- GM- AEJA- GM- AEJ 2717.1644 2717.1532 4.1 –10.7 +
GM- AEJA- GM- AEJA- GM- AEJA 
(double anhydro) 2748.1491 2748.1363 4.7 –11.0 +
GM- AEJA- GM- AEJA- GM- AEJA 
(anhydro) 2768.1753 2768.1674 2.9 –11.2 +
GM- AEJA- GM- AEJA- GM- AEJA 2788.2015 2788.1919 3.4 –9.7 +
GM- AEJA- GM- AEJA- GM- AEJK 
(anhydro) 2825.2379 2825.2205 6.1 –9.3 +
GM- GM- AEJA- GM- AEJA- GM- AEJ 3195.3622 3195.3264 11.2 –14.0 +
GM- GM- AEJA- GM- AEJA- GM- AEJA 3266.3993 3266.3630 11.1 –12.5 +
Alternative structures were matched:
GM- AEJ- GM- AEJK.
GM- AEJ- GM- AEJKA (anhydro).
GM- AEJ- GM- AEJKA.
GM- AEJ- GM- AEJA- GM- AEJKA (anhydro).
The online version of this article includes the following source data for table 2:
Source data 1. Pseudomonas aeruginosa matched muropeptides not reported previously.
Source data 2. Raw output of automated search using MaxQuant and PGFinder.
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has been designed to create dynamic databases that are ultimately combined to perform the final 
matching process. Optimisation of the search space relies on a preliminary identification of masses 
matching theoretical monoisotopic masses of monomers, limiting misidentifications based on mass 
coincidence. Another advantage is that the only information provided by the user is a restricted 
monomer database rather than a comprehensive one. This avoids a time- consuming operation, prone 
to human error. PGFinder uses XIC for quantification of PG fragments, providing high resolution, sensi-
tivity, and reproducibility, as indicated by the comparisons across biological replicates (Appendix 1—
figure 2 and Figure 4a). It enables the accurate quantification of molecules with overlapping retention 
times and those present in very low abundance, with a large dynamic range (typically six orders of 
magnitude). Although a Matlab- based software package (Chromanalysis) has been described to auto-
mate the detection and quantification of UV peaks through Gaussian fitting (Desmarais et al., 2015), 
quantification using XIC is more straightforward. It is worth pointing out that the approach described 
here does not give absolute quantification of muropeptides. Instead, it allows a relative quantification 
of muropeptides. Nevertheless, this strategy remains suitable for comparative analyses and over-
comes two major limitations associated with UV detection, namely detection threshold and co- elution 
of molecules.
Our E. coli PG analysis confirmed that PGFinder is a powerful tool that provides a much improved 
qualitative and quantitative PG analysis (Kühner et  al., 2014; Morè et  al., 2019). Combining an 
unbiased search with highly sensitive detection of individual structures is important for two reasons. 
Firstly, it opens the possibility to identify subtle modifications of PG structure, resulting from either 
a transient or a localised enzymatic activity such as that taking place at the septum. Secondly, it 
will permit the identification of previously undetected modifications that may provide new insights 
into our understanding of PG composition and dynamics. For example, we showed that E. coli PG 
contains a low abundance of deacetylated sugars. This observation is puzzling because no canonical 
PG deacetylase genes have been identified in this organism. Although the biological relevance of 
this property remains to be established, we cannot exclude the possibility that PG deacetylation in 
E. coli may contribute to PG homeostasis. Another striking outcome resulting from our automated 
search is the identification of a slightly higher amount of muropeptides containing anhydromuramic 
acid (4.55%) as compared to 2–3% (Glauner et al., 1988; Liu et al., 2020). To explain the discrepancy 
between our work and data from the literature, it is tempting to assume that most of the muropep-
tides containing anhydromuramic acid identified with PGFinder were simply not searched in previous 
studies. It is worth pointing out that none of the papers describing PG analysis published to date has 
reported the list of structures searched in the MS data analysed.
One of our objectives was to create an automated PG analysis tool accessible to the broadest 
audience possible, including people with no prior experience with programming or coding languages. 
Therefore, we shared PGFinder as a Jupyter Notebook allowing users to customise the search strategy 
depending on both the question asked and the instrument accuracy. PGFinder is particularly suitable 
for the characterisation of novel PGs with unknown composition or structural modifications and can 
be modified by users to add novel functionalities. However, a current limitation of this workflow is that 
it does not process MS/MS data. Therefore, the fragmentation spectra of individual monomers must 
be checked using dedicated tools to validate that the inferred structures are correct. We are currently 
working towards an integrated pipeline that includes MS/MS analysis to our PGFinder pipeline. The 
ability to disable some PG modifications means that the complexity of the search can be adjusted 
to focus on specific properties (e.g., the occurrence of acetylation/deacetylation, or amidation) or 
specific muropeptides resulting from lytic activities (e.g., unsubstituted MurNAc residues resulting 
from amidase activity). For PG that have already been well characterised (E. coli, P. aeruginosa, or C. 
difficile), the search parameters are already established, allowing a very straightforward analysis to be 
performed. Therefore, access to a custom, semi- quantitative sensitive analysis is ideal for comparing 
PG dynamics or differences in PG structure between a reference strain and isogenic mutants. Both 
reduced disaccharide peptides or lactyl- peptides (generated by beta- elimination) are identified using 
PGFinder.
We anticipate that an open access to PGFinder, in conjunction with freely available deconvolu-
tion tools, will allow researchers to carry out comparative MS1 analyses. The pipeline defined in this 
work enables reproducible and consistent data analysis. This represents the first step towards a stan-
dardised approach to PG analysis, opening the possibility to reanalyse datasets in repositories. The 
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modular structure of the open- source PGFinder code can be easily integrated into any specific work-
flow for the automated processing of PG MS data.
Materials and methods
Key resources table 
Reagent type (species) or 
resource Designation Source or reference Identifiers Additional information
Strain, strain background
(Escherichia coli) BW25113
https:// doi. org/ 10. 1073/ pnas. 
120163297 RRID:Addgene_72340 Model strain for PG analysis
Strain, strain background
(Clostridioides difficile) R20291 https:// doi. org/ 10. 1128/ JB. 0073107 Model strain for PG analysis
Strain, strain background
(Clostridioides difficile) M7404
https:// doi. org/ 10. 1371/ journal. ppat. 








v.3.9–32 Protein Metrics Inc
Used for MS data deconvolution 
and MS/MS analysis
Software, algorithm MaxQuant v2.0.1.0 Cox and Mann, 2008 RRID:SCR_014485 Used for MS data deconvolution
Software, algorithm Perseus
v.1.6.10.53
Tyanova et al., 2016 RRID:SCR_015753 Used statistical analysis of 
muropeptide abundance
Bacterial strains and culture conditions
E. coli BW25113 was grown at 37 °C in LB under agitation (250 rpm). C. difficile strains were cultured 
in heart infusion supplemented with yeast extract, L- cysteine, and glucose in an atmosphere of 10% 
H2, 10%  CO2, and 80% N2 at 37 °C in a Coy chamber or Don Whitley A300 anaerobic workstation.
PG purification
PG was purified from exponential (E. coli) or late exponential (C. difficile) phase as described previ-
ously (Eckert et  al., 2006; Glauner, 1988), freeze- dried, and resuspended in distilled water at a 
concentration of 5 mg/ml.
Preparation of soluble muropeptides
PG (1 mg) was digested overnight with 25 µg of mutanolysin at 37 °C in 150 µl of 20 mM sodium 
phosphate buffer (pH 5.5). Soluble disaccharide peptides were recovered in the supernatant following 
centrifugation (20,000 × g for 20 min at 25 °C). To reduce muropeptides, equal volumes (200 µl) of the 
solution of disaccharide peptides and of borate buffer (250 mM, pH 9.0) were mixed. 2 ml of sodium 
borohydride was added, and the solution was incubated for 20 min at room temperature. The pH of 
the solution was adjusted to 4.0 with 20%  orthophosphoric acid. Beta- elimination was carried out by 
mixing 200 µl of muropeptides with 64 µl of 32%  (w/v) ammonia. After 5 hr at 37 C, the solution was 
neutralised with 60 µl of acetic acid glacial, freeze- dried, and resuspended in water (Arbeloa et al., 
2004; Eckert et al., 2006).
The reduced muropeptides were desalted by reverse- phase high- performance liquid chromatog-
raphy (rp- HPLC) on a C18 Hypersil Gold aQ column (3 µm, 2.1 × 200 mm; Thermo Fisher) at a flow rate 
of 0.4 ml/min. After 1 min in water-0.1% formic acid (v/v) (buffer A), muropeptides were eluted with 
a 6 min linear gradient to 95%  acetonitrile-0.1% formic acid (v/v). Muropeptides were freeze- dried 
and resuspended in 100 µl. An aliquot of the desalted samples was analysed by rp- HPLC on the same 
column to measure the UV absorbance of the most abundant monomer (no isocratic step, muropep-
tides were eluted with a 30 min linear gradient to 15%  acetonitrile-0.1% formic acid [v/v]). Samples 
were diluted to contain 150 mAU/µl of the major monomer and 10 µl were injected. Based on the dry 
weight of the PG sample, we estimated that this corresponded to approximately 50 µg of material.
UHPLC-MS/MS
An Ultimate 3000 Ultra High- Performance Chromatography (UHPLC; Dionex/Thermo Fisher Scientific) 
system coupled with a high- resolution Q Exactive Focus mass spectrometer (Thermo Fisher Scientific) 
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was used for LC/HRMS analysis. Muropeptides were separated using a C18 analytical column (Hypersil 
Gold aQ, 1.9 µm particles, 150 × 2.1 mm; Thermo Fisher Scientific), column temperature at 50 °C. 
Muropeptides elution was performed by applying a mixture of solvent A (water, 0.1 % [v/v] formic 
acid) and solvent B (acetonitrile, 0.1 % [v/v] formic acid). After 10 µl sample injection, MS/MS data 
were acquired during a 40 min step gradient: 0–12.5% B for 25 min; 12.5–20% B for 5 min; held at 20%  
B for 5 min, and the column was re- equilibrated for 10 min under the initial conditions.
The Q Exactive Focus was operated under electrospray ionization (H- ESI II)- positive mode. Full 
scan (m/z 150–2250) used resolution 70,000 (FWHM) at m/z 200, with an automatic gain control (AGC) 
target of 1 × 106 ions and an automated maximum ion injection time (IT).
Data- dependent MS/MS were acquired on a ‘Top 3’ data- dependent mode using the following 
parameters: resolution 17,500; AGC 1 × 105  ions, maximum IT 50 ms, NCE 25 %, and a dynamic 
exclusion time 5 s.
MS data deconvolution
Byos search parameters to get .ftrs file Protein Metrics Byos v.3.9–32 was used to identify and compute 
the XICs. The parameters used for mass deconvolution using MaxQuant v.2.0.1.0 are described in 
Appendix 2—figure 2.
Data analysis
The crosslinking index and glycan chain length were calculated as described previously (Glauner, 
1988). Label- free relative quantitation of muropeptides from triplicate C. difficile clinical isolates 
(R20291 and M7404) was performed using Byos 3.11, and statistical analysis of the quantitative data 
was performed using Perseus v. 1.6.10.53 (Tyanova et al., 2016). Briefly, muropeptide intensities were 
log2 transformed and normalised by subtraction of the median value. A two- sample Student’s t- test 
was performed with a permutation- based FDR of 0.05 to determine statistically significant quantita-
tive differences between the strains. Comparisons between R20291 and M7404 muropeptide distribu-
tion (mono-, di-, tri-, tetra- pentamer) was evaluated for statistical significance using GraphPad Prism 
(unpaired t- test).
Runtime environment
Code is available at https:// github. com/ Mesnage- Org/ PGFinder (Patel, 2021). https:// github. com/ 
Mesnage- Org/ PGFinder/ releases/ tag/ v0. 02 will take you to the archived release used in this paper. 
We used Python 3 to write the MS1 package and demonstrate its functionality using demo scripts. 
PGFinder can be run through an interactive Jupyter Notebook hosted on mybinder for ease of use by 
those less familiar with Python code. A conda environment is provided to ensure reproducible execu-
tion. Regression testing has been implemented to ensure changes to code do not cause changes 
to important results. The GitHub contains an interactive version to run user’s analysis and an end- 
to- end demo using samples data provided with the script (Interactive PGFinder). The sample data 
is a MaxQuant deconvolution output from the E. coli MS data analysed in the paper. The current 
version of the script can handle both .txt (MaxQuant) or .ftrs (Byos) deconvoluted data and offers the 
possibility for the user to include several modifications in the search. The time window for the ‘clean 
up step’ (in- source decay and salt adducts) as well as ppm tolerance for matching can also be defined 
by the user; the default values corresponding to these parameters used in this work are 0.5 min and 
10 ppm.
Data availability
All E. coli and C. difficile MS datasets generated in this study are available through the GlycoPOST 
repository (GPST000168; Watanabe et  al., 2021). P. aeruginosa MS datasets are accessible via 
Figshare (Anderson et al., 2020b).
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Appendix 1
Appendix 1—figure 1. UHPLC- MS chromatogram of E. coli reduced disaccharide peptides.
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30.09% 28.97% 29.40% 29.49% 0.46%
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Appendix 1—figure 2. Consistency of E. coli PG analyses. (a) Pearson’s correlation coefficients 
across biological replicates of E. coli BW25113. (b) Muropeptide distribution according to degree 
of crosslinking. The crosslinking index was calculated as described previously (Glauner, 1988). 
(c) Pairwise comparisons of intensities corresponding to individual muropeptides identified in 
biological replicates. WT1, WT2 and WT3 correspond to individual biological replicates; Av., average 
abundance; SD, standard deviation.
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Appendix 2
Appendix 2—figure 1.  Workflow for production of MaxQuant compatible MS data files from Agilent 
QTOF data. Agilent MS data (data: .d) is converted by Proteowizard to a mzML format (data: XML). 
Relevant settings for Proteowizard are shown (left). mzML file is then converted by TOPPAS to a 
mzXML file (data: XML). Relevant settings are shown (right).
Appendix 2—figure 2. Workflow for MS data processing using MaxQuant, before automated 
analysis. mzXML (data: XML) is passed to MaxQuant (process) for deconvolution and monoisotopic 
mass determination. Default values used except where indicated (right). MaxQuant output (data: text 
file) is then passed to the data parser module (process). This module removes superfluous data and 
reformats remaining data to be compatible with the matching script as an Excel file (data: xlsx).
